221 related articles for article (PubMed ID: 30939618)
21. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
[TBL] [Abstract][Full Text] [Related]
22. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
[TBL] [Abstract][Full Text] [Related]
23. Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients.
Tokunaga M; Okimoto K; Akizue N; Ishikawa K; Hirotsu Y; Amemiya K; Ota M; Matsusaka K; Nishimura M; Matsushita K; Ishikawa T; Nagashima A; Shiratori W; Kaneko T; Oura H; Kanayama K; Ohta Y; Taida T; Saito K; Matsumura T; Chiba T; Mochizuki H; Arai M; Kato J; Ikeda JI; Omata M; Kato N
Sci Rep; 2021 Sep; 11(1):17671. PubMed ID: 34480065
[TBL] [Abstract][Full Text] [Related]
24. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
[TBL] [Abstract][Full Text] [Related]
25. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
[TBL] [Abstract][Full Text] [Related]
26. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study.
Thota PN; Hajifathalian K; Benjamin T; Runkana A; Lopez R; Sanaka MR
J Dig Dis; 2017 Mar; 18(3):143-150. PubMed ID: 28188977
[TBL] [Abstract][Full Text] [Related]
27. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
[TBL] [Abstract][Full Text] [Related]
28. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
Allen JE; Desai M; Roumans CAM; Vennalaganti S; Vennalaganti P; Bansal A; Falk G; Lieberman D; Sampliner R; Thota P; Vargo J; Gupta N; Moawad F; Bruno M; Kennedy KF; Gaddam S; Young P; Mathur S; Cash B; Spaander M; Sharma P
J Clin Gastroenterol; 2021 Apr; 55(4):321-326. PubMed ID: 32379085
[TBL] [Abstract][Full Text] [Related]
29. Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal Adenocarcinoma.
Solanky D; Krishnamoorthi R; Crews N; Johnson M; Wang K; Wolfsen H; Fleischer D; Ramirez FC; Katzka D; Buttar N; Iyer PG
J Clin Gastroenterol; 2019; 53(5):361-365. PubMed ID: 29608452
[TBL] [Abstract][Full Text] [Related]
30. Risk of recurrence of Barrett's esophagus after successful endoscopic therapy.
Krishnamoorthi R; Singh S; Ragunathan K; A Katzka D; K Wang K; G Iyer P
Gastrointest Endosc; 2016 Jun; 83(6):1090-1106.e3. PubMed ID: 26902843
[TBL] [Abstract][Full Text] [Related]
31. Review on the annual cancer risk of Barrett's esophagus in persons with symptoms of gastroesophageal reflux disease.
Lenglinger J; Riegler M; Cosentini E; Asari R; Mesteri I; Wrba F; Schoppmann SF
Anticancer Res; 2012 Dec; 32(12):5465-73. PubMed ID: 23225453
[TBL] [Abstract][Full Text] [Related]
32. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P
Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393
[TBL] [Abstract][Full Text] [Related]
33. Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.
Shaheen NJ; Smith MS; Odze RD
Gastrointest Endosc; 2022 Mar; 95(3):410-418.e1. PubMed ID: 34537193
[TBL] [Abstract][Full Text] [Related]
34. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database.
Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG
Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339
[TBL] [Abstract][Full Text] [Related]
35. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
36. Reduced Esophageal Contractility Is Associated with Dysplasia Progression in Barrett's Esophagus: A Multicenter Cohort Study.
Yadlapati R; Triggs J; Quader F; Eluri S; Bhatia S; Kaizer A; Pandolfino JE; Komanduri S; Gyawali P; Shaheen NJ; Menard-Katcher P; Wani S
Dig Dis Sci; 2020 Dec; 65(12):3631-3638. PubMed ID: 32026276
[TBL] [Abstract][Full Text] [Related]
37. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
38. Length of Barrett's esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.
Barrie J; Yanni F; Sherif M; Dube AK; Tamhankar AP
Surg Endosc; 2021 Aug; 35(8):4756-4762. PubMed ID: 32880012
[TBL] [Abstract][Full Text] [Related]
39. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
40. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.
Kestens C; Offerhaus GJ; van Baal JW; Siersema PD
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
